J Biol Chem 2005, 280:27412–27419. 10.1074/jbc.M50139320015917225CrossRefPubMed 26. Atienzar FA, Tilmant K, Gerets HH,

Toussaint G, Speeckaert S, Hanon E, Depelchin O, Dhalluin S: The use of real-time cell analyser technology in drug discovery: defining optimal cell culture conditions and assay reproducibility with different adherent cellular models. J Biomol Screen 2011,16(6):2011. doi:10.1177/1087057111402825CrossRef 27. Erbel P, Schiering N, D’Arcy A, Renatus M, Kroemer M, Lim S, Yin Z, Keller TH, Vasudevan SG, Hommel U: Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 2006, 13:372–373. 10.1038/nsmb107316532006CrossRefPubMed 28. Aleshin A, Shiryaev S, Strongin A, Liddington R: Structural evidence for regulation GSK2118436 and specificity of flaviviral

proteases and this website evolution of the Flaviviridae fold. Protein Sci 2007, 16:795–806. 10.1110/ps.072753207220664817400917CrossRefPubMedCentralPubMed Crizotinib 29. Mueller NH, Yon C, Ganesh K, Padmanabhan R: Characterization of the West Nile virus protease substrate specificity and inhibitors. Int J Biochem Cell Biol 2007, 39:606–614. 10.1016/j.biocel.2006.10.02517188926CrossRefPubMed 30. Leung D, Schroder K, White H, Fang N-X, Stoermer M, Abbenante G, Martin JL, Young PR, Fairlie DP: Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J Biol Chem 2001, 276:45762–45771. 10.1074/jbc.M10736020011581268CrossRefPubMed 31. Bodenreider C, Beer D, Keller TH, Sonntag S, Wen D, Yap L, Yau YH, Shochat SG, Huang D, Zhou T, Caflisch A, Su XC, Ozawa K, Otting G, Vasudevan SG, Lescar J, Lim SP: A fluorescence

quenching assay to discriminate Bupivacaine between specific and nonspecific inhibitors of dengue virus protease. Anal Biochem 2009,2009(395):195–204.CrossRef 32. Cregar-Hernandez L, Jiao GS, Johnson AT, Lehrer AT, Wong TA, Margosiak SA: Small molecule pan-dengue and West Nile virus NS3 protease inhibitors. Antivir Chem Chemother 2011, 21:209–217. 10.3851/IMP1767309551621566267CrossRefPubMedCentralPubMed 33. Li J, Lim SP, Beer D, Patel V, Wen D, Tumanut C, Tully DC, Williams JA, Jiricek J, Priestle JP, Harris JL, Vasudevan SG: Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J Biol Chem 2005, 280:28766–28774. 10.1074/jbc.M50058820015932883CrossRefPubMed 34. Gao Y, Cui T, Lam Y: Synthesis and disulfide bond connectivity-activity studies of a kalata B1-inspired cyclopeptide against dengue NS2B-NS3 protease. Bioorg Med Chem 2010, 18:1331–1336. 10.1016/j.bmc.2009.12.02620042339CrossRefPubMed 35. Dubovskii PV, Volynsky PE, Polyansky AA, Chupin VV, Efremov RG, Arseniev AS: Spatial structure and activity mechanism of a novel spider anti-microbial peptide. Biochemistry 2006, 45:10759–10767. 10.1021/bi060635w16939228CrossRefPubMed 36.